SCHEMBL17797706

SCHEMBL17797706

CC(C)(C)N1Cc2ccc(N)cc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.44
PDK2 Q15119 1/20 0.42
HSD17B3 P37058 1/20 0.40
KCNH2 Q12809 2/20 0.37
TMEM97 Q5BJF2 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
MAPT P10636 4/20 0.37
LMNA P02545 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NAMPT P43490 1/20 0.35
HDAC8 Q9BY41 3/20 0.33
ATAD2 Q6PL18 1/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13405609 0.85 NR1H2 (0.47) NR1H2PDK2HSD17B3MAPTLMNA
SCHEMBL17797585 0.85 NR1H2 (0.54) NR1H2PDK2HSD17B3MAPTLMNA
SCHEMBL6070593 0.80 NR1H2 (0.43) NR1H2PDK2HSD17B3KCNH2TMEM97
SCHEMBL18999610 0.78 DPP8 (0.39) KCNH2TMEM97SIGMAR1MAPTALDH1A1
SCHEMBL188773 0.77 KDM4E (0.43) NR1H2PDK2HSD17B3MAPTLMNA
SCHEMBL19700136 0.76 KCNH2 (0.59) KCNH2TMEM97SIGMAR1NAMPTDPP4
SCHEMBL13112861 0.76 ALDH1A1 (0.38) KCNH2TMEM97SIGMAR1MAPTLMNA
SCHEMBL26727548 0.76 HTR2A (0.38) HSD17B3KCNH2TMEM97SIGMAR1LMNA
SCHEMBL20706278 0.76 TMEM97 (0.44) KCNH2TMEM97SIGMAR1NAMPT
Hydrochloric Acid SCHEMBL30065224 0.75 MAPT (0.46) NR1H2PDK2HSD17B3MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160159774-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE CAR LLC (BM) 2016-06-09 US disclosed
WO-2016090079-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2016-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160159774-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 NR1H2 557/4885PDK2 1150/4885HSD17B3 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.